ID

33841

Descripción

Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Palabras clave

  1. 3/1/19 3/1/19 -
Titular de derechos de autor

GSK group of companies

Subido en

3 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032

Liver Event Assessments

Administrative data
Descripción

Administrative data

Site
Descripción

Site

Tipo de datos

text

Subject
Descripción

Subject

Tipo de datos

text

Visit Name
Descripción

Visit Name

Tipo de datos

text

Status
Descripción

Status

Tipo de datos

text

Document Number
Descripción

Document Number

Tipo de datos

text

Liver Events Assessment
Descripción

Liver Events Assessment

Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
Descripción

If Yes, stop investigational product, complete date stopped on Investigational Product form, contact GSK within 24 hours of occurrence, complete Liver Events Form and obtain the following test: 1.Blood sample for PK analysis, obtained within three half-lives(21 days) of last dose; 2.Hepatitis A: IgM antibody; 3, Hepatitis B surface antigen and Core Antibody (IgM); 4. Hepatitis C: RNA; 5.Hepatitis E IgM antibody (if subject resides or has travelled in past 3 month outside the USA or Canada); 6. Cytomegalovirus IgM antibody (CMV); 7. EBV (Epstein Barr Viral capsid antigen IgM antibody)or if unavailable, obtain heterophile antibody or monospot testing; 8.CPK (Serum creatine phosphokinase); 9. LDH (lactate dehydrogenase); 10. Bilirubin fractionation, if bilirubin >=1.5xULN (If ALT >=3xULN and bilirubin >1.5xULN(>35% direct), the following are needed: anti-nuclear antibody, anti-smooth muscle antibody, tape 1 anti-liver kidney microsomal antibodies, liver imaging).

Tipo de datos

boolean

Liver Events
Descripción

Liver Events

SAE / AE reference number
Descripción

SAE / AE reference number

Tipo de datos

integer

Date of assessment
Descripción

Date of assessment

Tipo de datos

date

Which liver chemistry result or exceeded protocol-defined investigational product stopping criteria?
Descripción

check all that apply

Tipo de datos

text

If Other, specify
Descripción

If Other, specify

Tipo de datos

text

Is the subject 55 or older?
Descripción

Is the subject 55 or older?

Tipo de datos

boolean

If female, is the subject pregnant?
Descripción

if Yes, complete the Pregnancy Notification Form

Tipo de datos

text

Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Descripción

Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?

Tipo de datos

boolean

If Yes, were the results normal?
Descripción

if No, record the details on the Non-Serious Adverse Events form or Serious Adverse Events form.

Tipo de datos

boolean

Were any liver biopsies performed?
Descripción

Were any liver biopsies performed?

Tipo de datos

boolean

Does the subject use herbals, complementary or alternative medicines?
Descripción

If Yes, record on the appropriate Concomitant Medication form

Tipo de datos

boolean

Did the subject fast or undergo significant dietary change in the past week?
Descripción

Did the subject fast or undergo significant dietary change in the past week?

Tipo de datos

boolean

Was a pharmacokinetic blood sample obtained?
Descripción

An unscheduled PK blood sample must be obtained within three half-lives (21 days) of last dose.

Tipo de datos

boolean

Date of sample taken
Descripción

Date of sample taken

Tipo de datos

date

Time of sample taken
Descripción

Time of sample taken

Tipo de datos

time

Record date and time of last investigational product dose prior to PK sample (if administered at subject's home, please do not record the time)
Descripción

Record date and time of last investigational product dose prior to PK sample (if administered at subject's home, please do not record the time)

Tipo de datos

datetime

Alcohol Intake
Descripción

Alcohol Intake

The average number of units of alcohol consumed per week:
Descripción

The average number of units of alcohol consumed per week:

Tipo de datos

integer

Unidades de medida
  • units per week
units per week
Liver Disease Medical Conditions
Descripción

Liver Disease Medical Conditions

1. Acute viral Hepatitis A
Descripción

1. Acute viral Hepatitis A

Tipo de datos

text

2. Chronic Hepatitis B
Descripción

2. Chronic Hepatitis B

Tipo de datos

text

3. Chronic Hepatitis C
Descripción

3. Chronic Hepatitis C

Tipo de datos

text

4. Cytomegalovirus Hepatitis
Descripción

4. Cytomegalovirus Hepatitis

Tipo de datos

text

5. Epstein Barr virus infectious mononucleosis
Descripción

5. Epstein Barr virus infectious mononucleosis

Tipo de datos

text

6. Herpes Simplex Hepatitis
Descripción

6. Herpes Simplex Hepatitis

Tipo de datos

text

7. Alcoholic liver disease
Descripción

7. Alcoholic liver disease

Tipo de datos

text

8. Non-alcoholic steatohepatitis
Descripción

8. Non-alcoholic steatohepatitis

Tipo de datos

text

9. Fatty Liver
Descripción

9. Fatty Liver

Tipo de datos

text

10. Hepatic Cirrhosis
Descripción

10. Hepatic Cirrhosis

Tipo de datos

text

11. Hemochromatosis
Descripción

11. Hemochromatosis

Tipo de datos

text

12. Autoimmune Hepatitis
Descripción

12. Autoimmune Hepatitis

Tipo de datos

text

13. Gallbladder disease or biliary disease
Descripción

13. Gallbladder disease or biliary disease

Tipo de datos

text

Drug Related Liver Disease Conditions
Descripción

Drug Related Liver Disease Conditions

14. Specific condition:
Descripción

specify here

Tipo de datos

text

Status of condition
Descripción

Status of condition

Tipo de datos

text

15. Specific condition
Descripción

15. Specific condition

Tipo de datos

text

Status of condition
Descripción

Status of condition

Tipo de datos

text

15. Specific condition
Descripción

15. Specific condition

Tipo de datos

text

Status of condition
Descripción

Status of condition

Tipo de datos

text

Other Medical Conditions
Descripción

Other Medical Conditions

17. Drug allergies
Descripción

17. Drug allergies

Tipo de datos

text

18. Rheumatoid Arthritis
Descripción

18. Rheumatoid Arthritis

Tipo de datos

text

19. Psoriasis
Descripción

19. Psoriasis

Tipo de datos

text

20. Thyroid disease
Descripción

20. Thyroid disease

Tipo de datos

text

21. Inflammatory bowel disease
Descripción

21. Inflammatory bowel disease

Tipo de datos

text

22. Lupus
Descripción

22. Lupus

Tipo de datos

text

23. Sjoren's syndrome
Descripción

23. Sjoren's syndrome

Tipo de datos

text

24. Vitiligo
Descripción

24. Vitiligo

Tipo de datos

text

Similar models

Liver Event Assessments

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative data
Site
Item
Site
text
Subject
Item
Subject
text
Item
Visit Name
text
Code List
Visit Name
CL Item
Liver Event Assessment (1)
Status
Item
Status
text
Document Number
Item
Document Number
text
Item Group
Liver Events Assessment
Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
Item
Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
boolean
Item Group
Liver Events
SAE / AE reference number
Item
SAE / AE reference number
integer
Date of assessment
Item
Date of assessment
date
Item
Which liver chemistry result or exceeded protocol-defined investigational product stopping criteria?
text
Code List
Which liver chemistry result or exceeded protocol-defined investigational product stopping criteria?
CL Item
ALT (alanine aminotransferase) (1)
CL Item
AST (aspartate aminotransferase) (2)
CL Item
Total bilirubin (3)
CL Item
Other (4)
If Other, specify
Item
If Other, specify
text
Is the subject 55 or older?
Item
Is the subject 55 or older?
boolean
Item
If female, is the subject pregnant?
text
Code List
If female, is the subject pregnant?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not Applicable (3)
Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Item
Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
boolean
If Yes, were the results normal?
Item
If Yes, were the results normal?
boolean
Were any liver biopsies performed?
Item
Were any liver biopsies performed?
boolean
Does the subject use herbals, complementary or alternative medicines?
Item
Does the subject use herbals, complementary or alternative medicines?
boolean
Did the subject fast or undergo significant dietary change in the past week?
Item
Did the subject fast or undergo significant dietary change in the past week?
boolean
Was a pharmacokinetic blood sample obtained?
Item
Was a pharmacokinetic blood sample obtained?
boolean
Date of sample taken
Item
Date of sample taken
date
Time of sample taken
Item
Time of sample taken
time
Record date and time of last investigational product dose prior to PK sample (if administered at subject's home, please do not record the time)
Item
Record date and time of last investigational product dose prior to PK sample (if administered at subject's home, please do not record the time)
datetime
Item Group
Alcohol Intake
The average number of units of alcohol consumed per week:
Item
The average number of units of alcohol consumed per week:
integer
Item Group
Liver Disease Medical Conditions
Item
1. Acute viral Hepatitis A
text
Code List
1. Acute viral Hepatitis A
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
2. Chronic Hepatitis B
text
Code List
2. Chronic Hepatitis B
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
3. Chronic Hepatitis C
text
Code List
3. Chronic Hepatitis C
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
4. Cytomegalovirus Hepatitis
text
Code List
4. Cytomegalovirus Hepatitis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
5. Epstein Barr virus infectious mononucleosis
text
Code List
5. Epstein Barr virus infectious mononucleosis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
6. Herpes Simplex Hepatitis
text
Code List
6. Herpes Simplex Hepatitis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
7. Alcoholic liver disease
text
Code List
7. Alcoholic liver disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
8. Non-alcoholic steatohepatitis
text
Code List
8. Non-alcoholic steatohepatitis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
9. Fatty Liver
text
Code List
9. Fatty Liver
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
10. Hepatic Cirrhosis
text
Code List
10. Hepatic Cirrhosis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
11. Hemochromatosis
text
Code List
11. Hemochromatosis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
12. Autoimmune Hepatitis
text
Code List
12. Autoimmune Hepatitis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
13. Gallbladder disease or biliary disease
text
Code List
13. Gallbladder disease or biliary disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item Group
Drug Related Liver Disease Conditions
14. Specific condition:
Item
14. Specific condition:
text
Item
Status of condition
text
Code List
Status of condition
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
15. Specific condition
Item
15. Specific condition
text
Item
Status of condition
text
Code List
Status of condition
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
15. Specific condition
Item
15. Specific condition
text
Item
Status of condition
text
Code List
Status of condition
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item Group
Other Medical Conditions
Item
17. Drug allergies
text
Code List
17. Drug allergies
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
18. Rheumatoid Arthritis
text
Code List
18. Rheumatoid Arthritis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
19. Psoriasis
text
Code List
19. Psoriasis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
20. Thyroid disease
text
Code List
20. Thyroid disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
21. Inflammatory bowel disease
text
Code List
21. Inflammatory bowel disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
22. Lupus
text
Code List
22. Lupus
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
23. Sjoren's syndrome
text
Code List
23. Sjoren's syndrome
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
24. Vitiligo
text
Code List
24. Vitiligo
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial